A morphological analysis endocrine tumour genesis in pancreas and anterior pituitary of AVP/SV40 transgenic mice
- PMID: 2829418
- DOI: 10.1007/BF00737150
A morphological analysis endocrine tumour genesis in pancreas and anterior pituitary of AVP/SV40 transgenic mice
Abstract
Insertion into the mouse genome of the hybrid oncogene made up of bovine vasopressin gene derived 5' upstream sequences and the coding sequences of SV40 large T-antigen promoted tumours in anterior pituitary and endocrine pancreas of mice bearing this transgene. In order to investigate the morphology of the steps in the neoplastic process, we used light and electron microscopy to study these organs in 42 animals belonging to the 3rd, 4th and 5th generations, subdivided into 4 age groups from 20 days to 100 days of life. Antibodies to large T-antigen were used to identify sites of expression of the hybrid oncogene, thus monitoring the steps in neoplastic transformation. Large T-antigen immunoreactivity was identified in dysplastic lesions of younger animals and in both dysplastic lesions and tumours of older mice. Insulin (100% of cases) and pancreatic polypeptide (25% of cases) immunoreactivities were revealed in pancreatic lesions but no hormonal immunoreactivity was detected in the pituitary lesions. The ultrastructural study confirmed that the majority cell population of the pancreatic neoplasms was B-type and that the anterior pituitary tumours were poorly granulated. The subcellular localization of large T-antigen immunoreactivity was investigated by the immunogold method and was confined to the heterochromatin of tumour cell nuclei. These findings provide evidence for the dysplasia-neoplasia sequence in the genesis of endocrine tumours of pituitary and pancreas of transgenic mice. The vasopressin-SV40 large T-antigen transgenic mice may therefore be an useful model for the study of endocrine cell oncogenesis.
Similar articles
-
Mice transgenic for a vasopressin-SV40 hybrid oncogene develop tumors of the endocrine pancreas and the anterior pituitary. A possible model for human multiple endocrine neoplasia type 1.Am J Pathol. 1987 Dec;129(3):552-66. Am J Pathol. 1987. PMID: 2827490 Free PMC article.
-
Morphology of adenohypophysial tumors in mice transgenic for vasopressin-SV40 hybrid oncogene.Endocrinology. 1992 Apr;130(4):1789-95. doi: 10.1210/endo.130.4.1312426. Endocrinology. 1992. PMID: 1312426
-
Glucagonomas of transgenic mice express a wide range of general neuroendocrine markers and bioactive peptides.Virchows Arch A Pathol Anat Histopathol. 1991;419(2):115-29. doi: 10.1007/BF01600225. Virchows Arch A Pathol Anat Histopathol. 1991. PMID: 1678563
-
Transgenic mouse models and peptide producing endocrine tumours: morpho-functional aspects.Experientia Suppl. 1989;56:210-9. doi: 10.1007/978-3-0348-9136-3_12. Experientia Suppl. 1989. PMID: 2522889 Review.
-
Oncogenic co-operation in beta-cell tumorigenesis.Endocr Relat Cancer. 2001 Dec;8(4):307-14. doi: 10.1677/erc.0.0080307. Endocr Relat Cancer. 2001. PMID: 11733227 Review.
Cited by
-
Human Insulinomas: Clinical, Cellular, and Molecular Aspects.Endocr Pathol. 1999 Winter;10(4):269-281. doi: 10.1007/BF02739769. Endocr Pathol. 1999. PMID: 12114763
-
Gut endocrine and neural peptides.Endocr Pathol. 1990 Mar;1(1):4-24. doi: 10.1007/BF02915151. Endocr Pathol. 1990. PMID: 32138398 Review.
-
Islet amyloid polypeptide in proliferating pancreatic B cells during development, hyperplasia, and neoplasia in humans and mice.Am J Pathol. 1991 Jun;138(6):1321-34. Am J Pathol. 1991. PMID: 1647136 Free PMC article.
-
Transgenic mice that develop pituitary tumors. A model for Cushing's disease.Am J Pathol. 1992 May;140(5):1071-80. Am J Pathol. 1992. PMID: 1316082 Free PMC article.
-
Prognostic factors in gastrointestinal endocrine tumors.Endocr Pathol. 2007 Fall;18(3):145-9. doi: 10.1007/s12022-007-0020-x. Endocr Pathol. 2007. PMID: 18058263 Review.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Medical
Miscellaneous